We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Additional vaccines will help ensure the UK can protect those that may be at high risk from mpox
The UK Health Security Agency responds to the World Health Organisation declaring an mpox outbreak a public health emergency of international concern.
Between June 2022 and May 2024, 15 ceftriaxone-resistant gonorrhoea cases were detected in England
Study shows new RSV vaccine for pregnant women could prevent 5,000 hospitalisations and 15,000 emergency department attendances for infants.
UKHSA urges pregnant women to get vaccinated to protect their newborn babies as whooping cough cases rise to over 10,000
To better understand Mpox and its spread within the UK, VDEC developed an immunoassay to assess immune responses to Mpox infection and new vaccines.
New data published today by the UK Health Security Agency (UKHSA) shows cases of whooping cough continue to increase with 2,591 cases confirmed in May.
UKHSA is working with partners to investigate a Shiga toxin-producing E. coli (STEC) outbreak.
From 1 July 2024, the vaccine used in the programme will change to ADACEL® (Tdap).
The Defence Science and Technology Laboratory (Dstl) is leading on the creation of the United Kingdom Microbial Forensics Consortium (UKMFC).
New data published today by the UK Health Security Agency (UKHSA) shows cases of whooping cough continue to increase with 1,319 cases confirmed in March.
Imported malaria cases diagnosed in 2023 exceed 2000 for the first time in over 20 years
UKHSA has published the latest data on scarlet fever cases in England. Scarlet fever is circulating, as expected for this time of year.
The aim is to develop a vaccine that provides cross-protection against the whole genus, addressing outbreaks, and enhancing epidemic preparedness.
TB cases are now above the pre-COVID-19-pandemic numbers
A new research project has been announced to evaluate an expansion of the hugely successful HIV opt-out testing programme to new sites across England.
First published during the 2022 to 2024 Sunak Conservative government
Latest report reveals continuous decline in HIV transmission but progress is slow among women and ethnic minorities.
The UK Health Security Agency (UKHSA) has detected a single confirmed human case of influenza A(H1N2)v.
The UK Health Security Agency (UKHSA) is monitoring reports of clusters of respiratory illness in children in northern China.
Public consultation supports proposal to update 3 regulations that ensure the safe and effective delivery of COVID-19 and influenza vaccination programmes.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).